Skip to main content
. 2024 Sep 12;11:1366460. doi: 10.3389/fcvm.2024.1366460

Table 1.

Patient profiles before propensity score matching.

Variable Unmatched cohorts
STS DuraGraft p SMD (%)
No. of patients (N) 294,725 2,522
Age 65.6 ± 9.9 67.3 ± 9.2 <0.001 18.1
Male sex 76.1% 82.5% <0.001 15.7
Black race 7.5% 0.1% <0.001 39.2
BMI < 20 kg/m2 1.7% 0.7% <0.001 8.9
Previous/current smoker 61.4% 62.1% 0.467 1.5
Diabetes—insulin 18.6% 14.5% <0.001 11.1
Diabetes—no insulin 31.6% 28.8% 0.002 6.2
CRF (Cr > 2.0 mg/dl) 2.0% 2.2% 0.474 1.5
Dialysis 3.1% 1.1% <0.001 13.4
PVD 22.0% 16.1% <0.001 15.1
PH 19.3% 8.2% <0.001 32.9
History of PD 15.9% 13.9% 0.007 5.6
History of CVA 11.2% 7.9% <0.001 11.3
MI ≤ 24 h 3.2% 1.4% <0.001 12.0
MI > 24 h 50.9% 41.4% <0.001 19.1
Unstable angina 34.9% 8.9% <0.001 66.2
Heart failure 24.6% 14.2% <0.001 26.4
Cardiogenic shock 1.3% 0.9% 0.077 4.0
Preop atrial fibrillation 9.7% 7.8% 0.002 6.5
Reoperation 1.6% 1.3% 0.193 2.9
Left main stem disease 26.1% 40.9% <0.001 31.8
Three-vessel disease 79.6% 81.2% 0.055 3.9
LVEF (<30%) 6.1% 3.1% <0.001 14.7
Status urgent 60.0% 24.1% <0.001 78.0
Status emergent 3.7% 1.3% <0.001 14.9
Previous CABGa 1.3% 0.3% <0.001 11.3
Previous PCIa 30.0% 24.6% <0.001 12.1
Intraoperative factors
On-pump statusa 88.8% 82.9% <0.001 17.0
No distal anastomosesa 3.41 ± 1.0 3.0 ± 0.9 <0.001 43.2
Use of LIMA grafta 97.3% 90.8% <0.001 27.5
No. of arterial graftsa 1.1 ± 0.5 1.3 ± .0.7 <0.001 28.5
No. of venous graftsa 2.2 ± 1.0 1.5 ± 0.9 <0.001 76.2
All-arterial graftsa 2.0% 10.4% <0.001 35.6
All venous graftsa 2.7% 5.3% <0.001 13.1
Endoscopic harvesta 89.9% 13.8% <0.001 235.1
a

Parameters only included in the primary model.

CABG, coronary artery bypass grafting; CRF, case report form; LIMA, left internal mammary artery; CVA, cerebrovascular accident; LVEF, left ventricular ejection fraction; PCI, percutaneous coronary intervention; PD, pulmonary disease; PH, pulmonary hypertension; PVD, peripheral vascular disease; SMD, standard mean difference; STS, Society of Thoracic Surgeons.